Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06263621
Other study ID # 855090
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 11, 2024
Est. completion date May 29, 2024

Study information

Verified date February 2024
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this this intervention is to test the degree to which a portion size labeling intervention influences consumer selection of smaller portions at two large cafés. The main question it aims to answer is: Do consumers order fewer calories when the portion size label for the smaller entree is called "standard" instead of "small"? Participants will order lunch as usual in the two cafes (one intervention, one control) for 5.5 months, and all order items will be recorded in the check-out system. One cafe will receive the labeling intervention, while the other will not. Researchers will compare the average calories per order between the two cafes to see if there are differences.


Description:

The investigators will work with two cafés that will start offering two size options for their entrées. The cafés will go through three phases: a baseline phase where there are two portion sizes and no intervention (6 weeks), an intervention phase where the portion size labeling strategy will be implemented (7 weeks), and then a final phase where the portion size intervention is removed (7 weeks). During the baseline period, the smaller-sized entrée will not receive a label, and the larger-sized entrée will be called "Large." During the intervention period for the control café, labeling will stay the same, but in the intervention café, the smaller size will be labeled "Standard" and the larger size will be called "Large." In the post-intervention period, the smaller-sized entrée in the intervention café will have no label so that it resembles the control café.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 12000
Est. completion date May 29, 2024
Est. primary completion date May 29, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - All customers who make a lunch purchase at the cafes Exclusion Criteria: - Purchases made outside of lunch service.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Intervention "Standard"
The two cafes will offer entrees in two sizes, a smaller and larger size. In the intervention cafe, the smaller size will be labeled "Standard" during the intervention period, and "Small" during all other times. In the control cafe, the smaller size will always be labeled "Small." The larger size will always be labeled "Large" for both cafes during the duration of the study.

Locations

Country Name City State
United States Courtyard Cafe Boston Massachusetts
United States Elements Cafe Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
University of Pennsylvania Restaurant Associates

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Average kcal per entree sold The primary outcome will be the average kcal per entrée purchased. Daily sales data for 5.5 months
Secondary Number of entrée units purchased Analyzing the number of entrée units purchased will enable the investigators to assess the impact of the intervention on entree sales. Daily sales data for 5.5 months
Secondary Total kcal per transaction This will allow the investigators to examine whether participants who ordered a reduced-sized entrée were ordering more calories in other parts of the meal (i.e., a dessert). Daily sales data for 5.5 months
Secondary Weekly gross sales This will allow the investigators to assess whether the addition of a reduced-sized entrée at a lower cost negatively affected lunch service revenue. Daily sales data for 5.5 months
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2